Is CBD safe? FDA Update Offers Little New Information

This post was originally published on this siteBut the agency’s hints about its enforcement priorities could be good news for some companies making cannabidiol products. Jim Crumly.

Read More

Co-Diagnostics Reports Surge in Demand for Coronavirus Tests

This post was originally published on this siteThe company’s shares have soared though it has offered few specifics about the financial impact its COVID-19 products are having. Jim Crumly.

Read More

NGM Biopharmaceuticals Reports a Successful NASH Trial

This post was originally published on this siteStrong results on multiple measures put the company’s drug candidate firmly in the NASH discussion. Jim Crumly. (TMFSpeyside). Feb 24, 2020 at

Read More

A Double Failure of Alzheimer’s Drugs

This post was originally published on this siteLilly and Roche reported their latest disappointments in attempting to effectively treat Alzheimer’s by attacking amyloid plaques. Jim Crumly.

Read More

Merck Announces a Big Planned Spinoff

This post was originally published on this siteMerck (NYSE: MRK) announced Wednesday its intention to spin off its women’s health business, legacy brands, and biosimilars unit into an

Read More

FDA Approves First Drug for Peanut Allergy

This post was originally published on this siteThe U.S. Food and Drug Administration (FDA) approved the first treatment for peanut allergies late Friday, and shares of the company that developed

Read More

Novavax Wins Fast-Track Designation for Flu Vaccine

This post was originally published on this siteShares of Novavax (NASDAQ: NVAX) were up more than 10% Wednesday after the company announced that the U.S. Food and Drug Administration (FDA)

Read More

Novavax Wins Fast-Track Designation for Flu Vaccine

This post was originally published on this siteShares of Novavax (NASDAQ: NVAX) were up more than 10% Wednesday after the company announced that the U.S. Food and Drug Administration (FDA)

Read More

Biogen Buys Azheimer’s and Parkinson’s Drug From Pfizer

This post was originally published on this siteBiogen (NASDAQ: BIIB) announced it has reached an agreement with Pfizer (NYSE: PFE) to buy a drug in early development that is designed to treat

Read More

What Happened in the Stock Market Today

This post was originally published on this siteStocks traded in a narrow range on low volume Thursday, with major benchmarks closing with mixed results as investors look forward to trade news

Read More